Strides Pharma Science Ltd

Strides Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Strides Pharma Science Ltd

₹ 877 -0.76%
26 Apr - close price
strides.com BSE: 532531 NSE : STAR
About

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.[1] The company's pharmaceutical products are sold in over 100 countries.[2]
The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.[3]

Key Points

About[1]
Incorporated in 1990, Strides operates in the pharmaceutical industry, manufacturing generic formulations in various dosage forms.

Website BSE NSE
  • Market Cap ₹ 8,067 Cr.
  • Current Price ₹ 877
  • High / Low ₹ 904 / 330
  • Stock P/E 92.1
  • Book Value ₹ 377
  • Dividend Yield 0.17 %
  • ROCE 1.89 %
  • ROE 0.61 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -1.53%
  • The company has delivered a poor sales growth of 4.76% over past five years.
  • Promoter holding is low: 25.9%
  • Company has a low return on equity of 2.73% over last 3 years.
  • Promoters have pledged 72.7% of their holding.
  • Company has high debtors of 257 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
421.09 633.60 508.79 575.00 439.56 455.66 423.19 481.24 386.51 563.56 475.32 540.29 520.02
367.67 545.58 500.61 528.04 435.92 437.82 484.22 486.77 340.91 444.13 419.75 497.02 454.37
Operating Profit 53.42 88.02 8.18 46.96 3.64 17.84 -61.03 -5.53 45.60 119.43 55.57 43.27 65.65
OPM % 12.69% 13.89% 1.61% 8.17% 0.83% 3.92% -14.42% -1.15% 11.80% 21.19% 11.69% 8.01% 12.62%
16.23 23.31 8.75 22.41 7.50 84.83 7.47 20.47 29.75 11.38 11.65 22.34 3.40
Interest 17.13 17.91 18.09 18.00 16.60 21.55 26.02 34.66 35.10 42.90 36.63 40.07 44.47
Depreciation 25.15 24.73 26.64 27.09 26.23 24.41 24.30 24.35 22.26 22.71 21.46 21.34 21.06
Profit before tax 27.37 68.69 -27.80 24.28 -31.69 56.71 -103.88 -44.07 17.99 65.20 9.13 4.20 3.52
Tax % 25.14% 30.02% 23.60% 23.72% 44.46% -253.57% 36.22% 90.92% 30.35% 4.29% 12.38% 69.29% 27.84%
20.49 48.08 -21.23 18.52 -17.60 200.50 -66.25 -4.00 12.54 62.40 8.00 1.28 2.54
EPS in Rs 2.29 5.36 -2.37 2.06 -1.96 22.33 -7.38 -0.44 1.39 6.91 0.89 0.14 0.28
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
750 712 1,064 929 2,162 1,382 1,470 1,537 1,692 1,858 1,979 1,854 2,099
637 616 914 795 1,894 1,255 1,271 1,402 1,487 1,698 1,902 1,755 1,815
Operating Profit 112 96 150 134 268 127 199 135 205 159 77 100 284
OPM % 15% 13% 14% 14% 12% 9% 14% 9% 12% 9% 4% 5% 14%
112 54 4,614 619 82 154 860 111 93 117 123 68 49
Interest 81 71 105 34 103 72 82 54 67 65 74 139 164
Depreciation 18 19 47 49 103 70 78 83 94 99 104 94 87
Profit before tax 126 60 4,612 669 145 139 899 109 136 112 22 -65 82
Tax % 7% 7% 24% 20% 10% 22% 1% -1% 12% 30% -738% 107%
118 56 3,513 532 130 109 892 110 120 78 180 5 74
EPS in Rs 20.19 9.52 589.42 89.32 14.58 12.14 99.62 12.33 13.43 8.72 20.07 0.52 8.22
Dividend Payout % 10% 21% 86% 121% 34% 37% 2% 24% 104% 29% 0% 289%
Compounded Sales Growth
10 Years: 10%
5 Years: 5%
3 Years: 3%
TTM: 20%
Compounded Profit Growth
10 Years: -14%
5 Years: -53%
3 Years: -44%
TTM: -39%
Stock Price CAGR
10 Years: 5%
5 Years: 13%
3 Years: -1%
1 Year: 160%
Return on Equity
10 Years: 7%
5 Years: 3%
3 Years: 3%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 58 59 60 60 89 89 90 90 90 90 90 90 90
Reserves 1,301 1,313 1,571 1,415 3,068 3,143 3,073 3,167 3,069 3,158 3,317 3,365 3,371
894 634 473 405 1,545 1,608 606 811 902 917 1,284 1,414 1,522
1,009 293 337 273 602 641 517 595 616 1,056 743 750 772
Total Liabilities 3,262 2,299 2,440 2,152 5,304 5,481 4,285 4,663 4,677 5,221 5,434 5,620 5,755
324 306 381 394 984 1,194 564 574 651 644 617 597 608
CWIP 7 30 37 39 180 158 144 122 112 111 56 55 34
Investments 787 1,295 1,047 968 2,447 2,520 1,777 2,149 2,171 2,395 2,400 2,492 2,492
2,145 668 976 750 1,693 1,609 1,801 1,818 1,743 2,072 2,361 2,476 2,621
Total Assets 3,262 2,299 2,440 2,152 5,304 5,481 4,285 4,663 4,677 5,221 5,434 5,620 5,755

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
98 11 -3 207 83 412 66 40 138 283 -283 242
-4 901 3,999 305 -1,062 -883 433 -166 63 -276 19 -183
-93 -962 -3,498 -802 1,571 -67 -707 123 -204 -49 251 11
Net Cash Flow 2 -50 497 -290 592 -538 -208 -3 -3 -42 -13 70

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 129 99 94 101 117 143 112 138 141 161 239 257
Inventory Days 110 98 80 110 113 204 126 197 189 254 170 168
Days Payable 177 134 127 133 148 234 183 212 200 271 213 220
Cash Conversion Cycle 62 63 47 77 82 112 55 123 130 144 196 205
Working Capital Days 204 131 100 97 120 110 150 178 150 162 231 261
ROCE % 6% 9% 11% 9% 6% 5% 24% 4% 5% 4% 2% 2%

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
29.62% 29.60% 29.60% 30.60% 30.37% 31.08% 30.90% 28.28% 28.08% 27.79% 27.39% 25.88%
25.80% 24.96% 19.85% 19.66% 21.21% 21.43% 18.98% 18.85% 16.72% 17.25% 19.45% 24.57%
14.62% 20.44% 21.08% 18.82% 16.63% 15.07% 18.44% 17.88% 19.60% 19.50% 19.02% 17.66%
0.00% 0.00% 0.00% 0.00% 0.00% 0.40% 0.40% 0.40% 0.40% 0.40% 0.39% 0.39%
29.96% 25.00% 29.47% 30.92% 31.79% 32.05% 31.29% 34.60% 35.22% 35.06% 33.75% 31.52%
No. of Shareholders 96,9761,06,9271,25,5531,33,1901,34,7181,30,6821,23,9641,20,9161,12,7751,01,63891,18284,695

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls